AVJennings (ASX:AVJ) has signed a scheme implementation deed with PM Nominees C, an investment entity of Proprium Capital Partners and AVID Property Group, to acquire all AVJennings shares for $0.655 ...

CG Oncology (NASDAQ:CGON), a clinical-stage biopharmaceutical company focused on developing innovative treatments for bladder cancer, today released its financial results for the year ended December ...

Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...

Neuren Pharmaceuticals (ASX:NEU) has announced the development of NNZ-2591 as a potential treatment for hypoxic-ischemic encephalopathy, a severe brain injury occurring in newborns due to insufficient ...